SOL Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-10,635
| Closed | -$265K | – | 228 |
|
|
2025
Q4 | $265K | Sell |
10,635
-2,515
| -19% | -$63.4K | 0.02% | 284 |
|
|
2025
Q3 | $335K | Sell |
13,150
-6,084
| -32% | -$150K | 0.03% | 259 |
|
|
2025
Q2 | $466K | Sell |
19,234
-32,798
| -63% | -$765K | 0.05% | 238 |
|
|
2025
Q1 | $1.32M | Sell |
52,032
-28,814
| -36% | -$754K | 0.15% | 140 |
|
|
2024
Q4 | $2.15M | Sell |
80,846
-38,116
| -32% | -$1.03M | 0.24% | 109 |
|
|
2024
Q3 | $3.44M | Sell |
118,962
-940
| -0.8% | -$27.4K | 0.38% | 71 |
|
|
2024
Q2 | $3.35M | Buy |
119,902
+3,709
| +3% | +$102K | 0.4% | 68 |
|
|
2024
Q1 | $3.22M | Buy |
116,193
+11,766
| +11% | +$326K | 0.41% | 71 |
|
|
2023
Q4 | $3.01M | Buy |
104,427
+18,845
| +22% | +$570K | 0.41% | 74 |
|
|
2023
Q3 | $2.84M | Buy |
85,582
+12,906
| +18% | +$456K | 0.44% | 68 |
|
|
2023
Q2 | $2.67M | Buy |
72,676
+18,462
| +34% | +$719K | 0.4% | 71 |
|
|
2023
Q1 | $2.21M | Buy |
54,214
+10,538
| +24% | +$455K | 0.36% | 86 |
|
|
2022
Q4 | $2.24M | Buy |
43,676
+340
| +0.8% | +$16.3K | 0.4% | 79 |
|
|
2022
Q3 | $1.9M | Sell |
43,336
-300
| -0.7% | -$14.6K | 0.39% | 79 |
|
|
2022
Q2 | $2.29M | Buy |
43,636
+7,280
| +20% | +$371K | 0.46% | 65 |
|
|
2022
Q1 | $1.88M | Buy |
36,356
+1,185
| +3% | +$61.5K | 0.34% | 84 |
|
|
2021
Q4 | $2.08M | Sell |
35,171
-315
| -0.9% | -$15.6K | 0.38% | 78 |
|
|
2021
Q3 | $1.53M | Sell |
35,486
-20
| -0.1% | -$886 | 0.3% | 85 |
|
|
2021
Q2 | $1.39M | Buy |
35,506
+1,148
| +3% | +$44.6K | 0.28% | 91 |
|
|
2021
Q1 | $1.25M | Buy |
34,358
+1,917
| +6% | +$68.1K | 0.26% | 95 |
|
|
2020
Q4 | $1.19M | Sell |
32,441
-559
| -2% | -$20.5K | 0.28% | 94 |
|
|
2020
Q3 | $1.15M | Sell |
33,000
-155
| -0.5% | -$5.43K | 0.32% | 85 |
|
|
2020
Q2 | $1.03M | Sell |
33,155
-1,054
| -3% | -$35.8K | 0.29% | 88 |
|
|
2020
Q1 | $1.06M | Sell |
34,209
-685
| -2% | -$23.3K | 0.35% | 79 |
|
|
2019
Q4 | $1.3M | Sell |
34,894
-882
| -2% | -$31.4K | 0.33% | 84 |
|
|
2019
Q3 | $1.22M | Sell |
35,776
-699
| -2% | -$25.4K | 0.33% | 91 |
|
|
2019
Q2 | $1.5M | Hold |
36,475
| – | – | 0.41% | 75 |
|
|
2019
Q1 | $1.47M | Sell |
36,475
-1,644
| -4% | -$65.8K | 0.41% | 75 |
|
|
2018
Q4 | $1.58M | Sell |
38,119
-1,042
| -3% | -$43.3K | 0.5% | 62 |
|
|
2018
Q3 | $1.64M | Sell |
39,161
-281
| -0.7% | -$10.8K | 0.44% | 69 |
|
|
2018
Q2 | $1.36M | Buy |
39,442
+15
| +0% | +$513 | 0.39% | 75 |
|
|
2018
Q1 | $1.33M | Buy |
39,427
+199
| +0.5% | +$6.84K | 0.38% | 77 |
|
|
2017
Q4 | $1.35M | Sell |
39,228
-8,695
| -18% | -$296K | 0.39% | 77 |
|
|
2017
Q3 | $1.62M | Sell |
47,923
-1,529
| -3% | -$49.1K | 0.46% | 64 |
|
|
2017
Q2 | $1.58M | Sell |
49,452
-2,811
| -5% | -$88.6K | 0.43% | 65 |
|
|
2017
Q1 | $1.7M | Sell |
52,263
-1,196
| -2% | -$37.7K | 0.48% | 56 |
|
|
2016
Q4 | $1.65M | Buy |
53,459
+687
| +1% | +$21K | 0.5% | 52 |
|
|
2016
Q3 | $1.7M | Sell |
52,772
-737
| -1% | -$24.6K | 0.57% | 42 |
|
|
2016
Q2 | $1.79M | Hold |
53,509
| – | – | 0.6% | 37 |
|
|
2016
Q1 | $1.5M | Buy |
53,509
+258
| +0.5% | +$7.37K | 0.51% | 48 |
|
|
2015
Q4 | $1.63M | Sell |
53,251
-192
| -0.4% | -$6.04K | 0.58% | 41 |
|
|
2015
Q3 | $1.59M | Buy |
53,443
+1,692
| +3% | +$54.3K | 0.61% | 42 |
|
|
2015
Q2 | $1.65M | Sell |
51,751
-4,075
| -7% | -$133K | 0.6% | 42 |
|
|
2015
Q1 | $1.84M | Sell |
55,826
-2,955
| -5% | -$93.9K | 0.68% | 36 |
|
|
2014
Q4 | $1.74M | Sell |
58,781
-3,109
| -5% | -$89.1K | 0.67% | 35 |
|
|
2014
Q3 | $1.74M | Sell |
61,890
-6,494
| -9% | -$182K | 0.72% | 30 |
|
|
2014
Q2 | $1.93M | Sell |
68,384
-1,370
| -2% | -$39.1K | 0.77% | 28 |
|
|
2014
Q1 | $2.13M | Sell |
69,754
-7,722
| -10% | -$230K | 0.83% | 21 |
|
|
2013
Q4 | $2.25M | Buy |
77,476
+2,526
| +3% | +$73.5K | 0.86% | 18 |
|
|
2013
Q3 | $2.04M | Sell |
74,950
-21,225
| -22% | -$578K | 0.85% | 15 |
|
|
2013
Q2 | $2.56M | Buy |
+96,175
| New | +$2.66M | 1.04% | 13 |
|
Other funds holding PFE
SOL Capital Management's PFE Position: Q1 2026 in Review
SOL Capital Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 10,635 shares — an estimated $265K sold.
SOL Capital Management first reported a position in PFE in Q2 2013 and held it in 51 quarters. The position peaked at $3.44M in Q3 2024. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- SOL Capital Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- SOL Capital Management sold 10,635 Pfizer shares in Q1 2026, an estimated $265K.
- SOL Capital Management first reported a position in Pfizer in Q2 2013 and held it in 51 quarters.
- SOL Capital Management's Pfizer position peaked at $3.44M in Q3 2024.
- 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on SOL Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.